PTEN was downregulated in both osteosarcoma cell lines and clinical samples, and is a verified target of miR-26a and members of the miR-106b-25 and miR-17-92 clusters [54], [55], [56], [57]. This evidence concerns the gene PTEN and osteosarcoma.